Report : South and Central America Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Method, and CTC Analysis), Application (Clinical/Liquid Biopsy, and Research), and End-User (Hospitals and Clinics, Research and Academic Institutes, and Diagnostic Centers)
CTC Detection and Enrichment Method Segment has the Largest Share of Technology in the South & Central America Circulating Tumor Cell (CTC) Diagnostics Market during 2021–2028
According to our latest study on “South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 – COVID-19 Impact and Analysis – by Technology, Application, and End User,” the market is projected to reach US$ 214.0 million by 2028 from US$ 116.9 million in 2021; it is expected to grow at a CAGR of 9.0% from 2021 to 2028. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the increasing prevalence of cancer across the region along with rising demand for minimally invasive diagnostic procedures. However, dearth of skilled professionals performing diagnostic procedures is expected to restrict the market growth during the forecast period.
Brazil, Argentina, Uruguay, Chile, Peru, Colombia is concerned by the second wave of corona infection. Amongst which Brazil has registered the majority of the deaths. Moreover, Covid-19 impacted the number of patients undergoing cancer diagnosis, screening and treatment. The rising rate of covid-19 across the globe enforced majority of pharmaceutical and biotechnology companies to development novel therapies and diagnostics for covid-19 which significantly impacted on the circulating tumor cell diagnostics market growth. Moreover, Continuous strain due to the COVID-19 outbreak has further impacted, supply chains, company operations, and distribution systems including their ability to research and develop, and novel product launches and services in the market. Thus, the covid-19 pandemic is expected to have a negative impact on Circulating Tumor Cell (CTC) diagnostics market in SCAM region during the forecast period.
Based on technology, the circulating tumor cell (CTC) diagnostics market is segmented into CTC detection and enrichment method, CTC direct detection and CTC analysis. In 2021, the CTC detection and enrichment segment accounted for the highest share, moreover the same segment is expected to grow at a CAGR of 10.2% in the forecast period.
Thermo Fisher Scientific, Stemcell Technologies, Inc, QIAGEN, Advanced Cell Diagnostics (Bio-Techne Corporation), and Fluxion Biosciences are among the leading companies in the South & Central America circulating tumor cell (CTC) diagnostics market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
The market for circulating tumor cell (CTC) diagnostics market is segmented into technology, application, and end user. Based on technology, the South & Central America circulating tumor cell (CTC) diagnostics market is segmented into CTC detection and enrichment method, CTC direct detection and CTC analysis. Based on application, the circulating tumor cell (CTC) diagnostics market is segmented into clinical/liquid biopsy, and research. Based on end user, the circulating tumor cell (CTC) diagnostics market is segmented into hospitals and clinics, research and academic institutes, and diagnostic centers. Geographically, the circulating tumor cell (CTC) diagnostics market is segmented into South & Central America (Brazil, Argentina, Rest of South & Central America).
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com